RICE HALL JAMES & ASSOCIATES, LLC Portfolio

Auto-discovered 13F filer (Top-2000 by latest reported value).

SEC 13F CIK: 0001230765

What is a 13F filing? Who files one and when · What 13F filings can't tell you

MidHigh Turnover how tags are computed

Q3 2024 · 250 positions · Total reported value $1.85B · Top-10 concentration 26.2% · Updated 2026-10-18

Last updated: 2026-10-18 · Source: SEC EDGAR Form 13F-HR

Turnover: 77.5% · 9 new · 172 cut · 12 exited

Active Share (vs S&P 500): 98.5% · vs QQQ: 99.5% — share of the book that differs from index weights (higher = more active) · ranking

Est. Qtr Return (Q2 2026 → Q3 2026): -4.7% · vs SPY -6.9% · Prev Value $2.05B — last quarter positions weighted by this quarter price moves · ranking

Est. QTD Return (Q3 2026 → newest close): +5.1% · vs SPY +3.0% · Latest Value $1.89B — latest reported positions valued at quarter-to-date price moves (still in progress) · ranking

In its Q3 2024 13F filing, RICE HALL JAMES & ASSOCIATES, LLC disclosed 250 equity positions with a combined reported value of $1.85B. The filing implies a moderately concentrated portfolio: its ten largest positions account for 26.2% of reported value. HoldingsHub classifies the profile as Mid / High Turnover.

The largest disclosed positions as of Q3 2024 were LRN ($70.97M), DFIN ($59.22M), ACIW ($54.56M). By sector, the heaviest allocations are Consumer Discretionary 28.3%, Health Care 25.2%. Versus the prior quarter, allocation shifted toward Technology (+2.5pp), Consumer Discretionary (+1.8pp) and away from Other (-1.0pp), Financials (-1.1pp).

Versus the prior quarter, RICE HALL JAMES & ASSOCIATES, LLC opened 9 new positions, trimmed 172 and fully exited 12, a turnover rate of 77.5% of positions. The portfolio's overlap with the prior quarter was 86% of names.

The largest new positions opened in Q3 2024 were GNTX ($8.47M), MGPI ($6.55M), VCYT ($4.33M).

Of the 12 positions fully exited versus the prior quarter, the largest were RXO ($8.37M), WKME ($4.73M), QLYS ($4.27M).

Figures come from the fund's SEC Form 13F filing. 13F reports are filed within 45 days of quarter end and cover long positions of $100,000 or more; they exclude short positions and non-13F asset classes, so treat this page as a quarter-end snapshot rather than the fund's live book.

New Positions (Q3 2024)

  • GNTX GENTEX CORP · $8.47M
  • MGPI MGP INGREDIENTS INC NEW · $6.55M
  • VCYT VERACYTE INC · $4.33M
  • HWKN HAWKINS INC · $4.02M
  • DCBO DOCEBO INC · $3.91M
  • MLTX MOONLAKE IMMUNOTHERAPEUTICS · $3.81M
  • GPGI GPGI INC · $3.77M
  • OMCL OMNICELL COM · $2.72M

Fully Exited (vs previous quarter)

  • RXO RXO INC · prev qtr: $8.37M
  • WKME WALKME LTD · prev qtr: $4.73M
  • QLYS QUALYS INC · prev qtr: $4.27M
  • PWSC POWERSCHOOL HOLDINGS INC · prev qtr: $4.00M
  • PINC PGIM ETF TR · prev qtr: $3.82M
  • RYTM RHYTHM PHARMACEUTICALS INC · prev qtr: $3.82M
  • LUCK LUCKY STRIKE ENTERTAINMENT C · prev qtr: $3.27M
  • SRDX SURMODICS INC · prev qtr: $2.74M

Insider Transactions (Form 4)

Latest RICE HALL JAMES & ASSOCIATES, LLC buys and sells reported on SEC Form 4 — filed within two business days when the fund's ownership in a stock crosses 10%.

No Form 4 filings for this fund yet — when its ownership in a stock crosses 10%, buys and sells are filed here within two business days.

Fund Profile

Rice Hall James & Associates, based in San Diego, CA, United States, files quarterly US equity holdings with the SEC on Form 13F. Its latest filing (Q2 2026) lists 240 positions worth $2.05B in total. HoldingsHub carries 12 quarters of its filings (Q3 2023–Q2 2026).

Firm Snapshot

  • Headquarters: SAN DIEGO, CA, United States
  • SEC registration: 801-61905 (status: Approved), registered 2003-02-13
  • Regulatory AUM (Form ADV): $1.74B as of 2026-05-06
  • Client mix (by RAUM): pension and profit-sharing plans 62%, individual investors 30%
  • Website: ricehalljames.com

Portfolio Structure

  • 240 positions · $2.05B reported value (Q2 2026)
  • Top 10 holdings = 24.1% of reported value
  • Largest position: LGND (LIGAND PHARMACEUTICALS INC) at 4.2%
  • Average position size: $8.56M

Sector Tilt

  • Health Care 31.6%
  • Consumer Discretionary 25.0%
  • Information Technology 20.2%
  • (classified holdings cover 99% of value)

Quarterly Activity

  • Q2 2026: 12 new, 94 added, 97 reduced, 15 exited
  • 37 positions unchanged

Generated from the firm's public SEC Form 13F and ADV filings. It states what the firm has reported — not an evaluation of its strategy, and not investment advice.

Sector Allocation

Health Care 25.2%
Technology 16.7%
Financials 5.2%
Other 12.3%
Sort by: Value · CSV
# Shares Value Weight Allocation Change
1 831.85K $70.97M 3.84%
3.84%
Reduce
2 899.57K $59.22M 3.21%
3.21%
Add
3 1.07M $54.56M 2.95%
2.95%
Reduce
4 4.07M $49.28M 2.67%
2.67%
Add
5 388.49K $48.06M 2.60%
2.60%
Reduce
6 1.37M $45.56M 2.47%
2.47%
Add
7 829.24K $43.71M 2.37%
2.37%
Reduce
8 573.53K $41.35M 2.24%
2.24%
Reduce
9 109.80K $36.65M 1.98%
1.98%
Reduce
10 793.30K $34.33M 1.86%
1.86%
Add
11 342.32K $33.97M 1.84%
1.84%
Reduce
12 154.03K $32.31M 1.75%
1.75%
Add
13 172.13K $32.26M 1.75%
1.75%
Add
14 312.88K $31.32M 1.70%
1.70%
Add
15 130.60K $30.88M 1.67%
1.67%
Reduce
16 985.08K $28.34M 1.53%
1.53%
Add
17 262.54K $28.23M 1.53%
1.53%
Reduce
18 206.95K $27.20M 1.47%
1.47%
Reduce
19 600.81K $26.18M 1.42%
1.42%
Reduce
20 501.31K $24.39M 1.32%
1.32%
Add
21 261.31K $24.27M 1.31%
1.31%
Add
22 160.61K $23.98M 1.30%
1.30%
Add
23 549.14K $22.59M 1.22%
1.22%
Add
24 931.65K $20.76M 1.12%
1.12%
Add
25 1.01M $18.73M 1.01%
1.01%
Add
26 529.39K $18.72M 1.01%
1.01%
Add
27 540.79K $16.86M 0.91%
0.91%
Add
28 2.16M $16.44M 0.89%
0.89%
Add
29 649.63K $16.23M 0.88%
0.88%
Add
30 173.78K $16.19M 0.88%
0.88%
Reduce
31 1.68M $15.77M 0.85%
0.85%
Add
32 94.28K $15.76M 0.85%
0.85%
Reduce
33 86.47K $15.16M 0.82%
0.82%
Add
34 535.11K $14.82M 0.80%
0.80%
Add
35 379.67K $14.81M 0.80%
0.80%
Add
36 904.90K $14.66M 0.79%
0.79%
Add
37 167.02K $14.61M 0.79%
0.79%
Add
38 314.88K $14.16M 0.77%
0.77%
Add
39 174.04K $14.01M 0.76%
0.76%
Reduce
40 36.90K $13.90M 0.75%
0.75%
Reduce
41 516.70K $13.71M 0.74%
0.74%
Add
42 117.42K $13.53M 0.73%
0.73%
Reduce
43 309.35K $13.30M 0.72%
0.72%
Reduce
44 451.66K $12.64M 0.68%
0.68%
Reduce
45 100.59K $12.13M 0.66%
0.66%
Reduce
46 2.72M $11.52M 0.62%
0.62%
Add
47 717.15K $11.03M 0.60%
0.60%
Reduce
48 452.54K $10.93M 0.59%
0.59%
Add
49 62.31K $10.86M 0.59%
0.59%
Reduce
50 191.06K $10.61M 0.57%
0.57%
Add

FAQ

What did RICE HALL JAMES & ASSOCIATES, LLC buy in 2024-Q3?

In its 2024-Q3 13F filing, RICE HALL JAMES & ASSOCIATES, LLC reported 250 equity positions worth $1.85B in aggregate; its largest disclosed positions were LRN ($70.97M), DFIN ($59.22M), ACIW ($54.56M).

How large is RICE HALL JAMES & ASSOCIATES, LLC's portfolio?

RICE HALL JAMES & ASSOCIATES, LLC reported $1.85B of long equity holdings across 250 positions as of 2024-Q3. Top-10 holdings account for 26.2% of reported value.

What is RICE HALL JAMES & ASSOCIATES, LLC's investment style?

HoldingsHub classifies the portfolio as Mid / High Turnover, computed from size, concentration, sector tilt and turnover.

Where does this data come from?

All figures are computed from the fund's SEC Form 13F quarterly filing, which must be filed within 45 days of quarter end for long positions of $100,000 or more.

Embed this fund on your site

Copy the snippet below to show this fund's live top holdings on your blog or forum — free, auto-updating, links back to HoldingsHub.

<iframe src="https://holdingshub.top/funds/rice-hall-james-and-associates/widget" width="100%" height="520" frameborder="0" loading="lazy" title="HoldingsHub fund holdings"></iframe>

Preview the embeddable widget →